CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Oct. 01, 2016	Sep. 26, 2015
Cash Flows from Operating Activities:
Net income	$ 9,479	$ 12,596
Non-cash items:
Depreciation and amortization	45,253	44,998
Asset impairments	2,505	88
Stock compensation expense	4,235	3,883
Unrealized gain from hedging activities	(1,674)	(710)
Provision for losses on accounts receivable and inventory	6,902	3,080
Other non-cash operating activities	433	745
Change in operating assets and liabilities:
Change in accounts receivable	6,807	(287)
Change in inventories	(12,661)	(40)
Change in prepaid income taxes	(324)	(182)
Change in other assets and other liabilities	2,836	(337)
Change in accounts payable and accrued expenses	6,169	(27,073)
Net cash provided by operating activities	69,960	36,761
Cash Flows from Investing Activities:
Capital expenditures	(41,624)	(50,130)
Proceeds from sale of property, plant and equipment	197	293
Other acquisitions and investments	0	(3,000)
Net cash used in investing activities	(41,427)	(52,837)
Cash Flows from Financing Activities:
Payments on long-term real estate mortgage	0	(558)
Net (decrease) increase in short-term loans	(1,116)	6,924
Repayment of term loan borrowings	(18,970)	0
Proceeds from employee stock purchase plan	1,979	2,263
Proceeds from exercise of stock options	13,532	8,374
Share repurchases	0	(60,984)
Net cash used in financing activities	(4,575)	(43,981)
Effect of exchange rates on cash and cash equivalents	(211)	(358)
Net Change in Cash and Cash Equivalents	23,747	(60,415)
Cash and Cash Equivalents at Beginning of Period	115,123	160,662
Cash and Cash Equivalents at End of Period	138,870	100,247
Supplemental Disclosures of Cash Flow Information:
Interest paid	4,118	4,162
Income taxes paid	3,867	4,656
Transfers from inventory to fixed assets for placement of Haemonetics equipment	$ 3,477	$ 5,550